DBV Technologies S.A. Stock Forecast NASDAQ:DBVT

Price Target and Analyst Ratings

Most Recent Rating

On September 14, 2021 "Societe Generale" gave "" rating for DBVT. The price target was changed from $4.84 to 3.8%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-09-14		Upgraded by	Societe Generale	$4.94	$4.84→3.8%
2021-05-04	Sell - Hold	Upgraded by	Societe Generale	$6.51
2021-05-03	Sell - Buy	Upgraded by	Bryan, Garnier & Co	$6.15
2021-03-12	Outperform	Reiterated by	SVB Leerink	$5.99
2021-01-22	Hold - Sell	Downgraded by	Societe Generale	$5.93
2021-01-18		Target Raised by	The Goldman Sachs Group	$5.66	$4.00 → $7.00
2021-01-15		Target Raised by	Citigroup	$5.66	$4.00 → $8.00
2020-11-02	Sell - Hold	Upgraded by	Societe Generale	$1.76
2020-08-11	Hold	Reiterated by	Jefferies Financial Group	$2.30	$2.50
2020-08-06	Buy - Sell	Downgraded by	Societe Generale	$2.32
2020-08-05	Buy	Target Lowered by	HC Wainwright	$2.48	$25.00 → $14.00
2020-08-05	Buy	Target Lowered by	Citigroup	$2.48	$10.00 → $4.00
2020-08-05	Equal Weight	Target Lowered by	Morgan Stanley	$2.48	$4.00 → $2.00
2020-08-04	Neutral - Sell	Downgraded by	Bryan, Garnier & Co	$2.34
2020-07-02	Buy	Initiated by	JMP Securities	$4.47	$10.00
2020-06-26	Hold	Reiterated by	Stifel Nicolaus	$4.66

DBVT Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -7.48% during the next 3 months and, with a 90% probability hold a price between $4.14 and $5.39 at the end of this 3-month period.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-22	$4.47	$5.14	$5.82
2021-09-23	$4.46	$5.14	$5.81
2021-09-24	$4.46	$5.13	$5.80
2021-09-27	$4.45	$5.12	$5.79
2021-09-28	$4.44	$5.11	$5.79
2021-09-29	$4.43	$5.11	$5.78
2021-09-30	$4.43	$5.10	$5.77
2021-10-01	$4.42	$5.09	$5.76
2021-10-04	$4.41	$5.08	$5.76
2021-10-05	$4.40	$5.08	$5.75
2021-10-06	$4.40	$5.07	$5.74
2021-10-07	$4.39	$5.06	$5.73
2021-10-08	$4.38	$5.05	$5.73
2021-10-11	$4.37	$5.05	$5.72
2021-10-12	$4.37	$5.04	$5.71
2021-10-13	$4.36	$5.03	$5.70
2021-10-14	$4.35	$5.02	$5.70
2021-10-15	$4.34	$5.02	$5.69
2021-10-18	$4.34	$5.01	$5.68
2021-10-19	$4.33	$5.00	$5.67
2021-10-20	$4.32	$4.99	$5.67
2021-10-21	$4.31	$4.99	$5.66
2021-10-22	$4.31	$4.98	$5.65
2021-10-25	$4.30	$4.97	$5.64
2021-10-26	$4.29	$4.96	$5.64
2021-10-27	$4.28	$4.96	$5.63
2021-10-28	$4.28	$4.95	$5.62
2021-10-29	$4.27	$4.94	$5.61
2021-11-01	$4.26	$4.93	$5.61
2021-11-02	$4.25	$4.93	$5.60

About DBV Technologies S.A.

DBV Technologies SA DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product which is in Phase III clinical trials for the treatment of peanut allergies in children, adolescents, and adults. The company is also developing Viaskin Milk that is in Phase II clinical trials for the treatment of CMPA and milk-ind... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!